Mozes kriebel schreef op 3 februari 2020 15:52:
Op twitter ook interessant bericht van CEO:
Als antwoord op
@LABINNOVATIONS
@PrimerdesignLtd
en 2 anderen
Graham Mullis, CEO of #Novacyt
"Over the last few days, we have seen significant early demand for our genesig(R) 2019-nCoV test from over 10 COUNTRIES.
We believe our assay is the first European test to be made available & introduced at the #Medlab2020
@expo2020dubai
#NCYT